Wyeth, Schering-Plough, Novartis post first quarter profits
Wyeth, Schering-Plough and Novartis each posted strong growth of prescription drug sales for the first quarter of 2005.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.